Bristol-Myers Squibb appoints three new independent directors
Bristol-Myers announced it has appointed Robert J. Bertolini, Matthew W. Emmens and Theodore R. Samuelsto its Board. Bertolini is the former president and CFO of Bausch & Lomb; Emmens is the former chairman, president and CEO of Vertex; and Samuels is the former president of Capital Guardian Trust. February 21, 2017